149 related articles for article (PubMed ID: 25348345)
1. Phosphorylated insulin-like growth factor-1 receptor expression predicts poor prognosis of Chinese patients with gastric cancer.
Deng WY; Li N; Wan XB; Luo SX; Zhang YW
Med Oncol; 2014 Dec; 31(12):141. PubMed ID: 25348345
[TBL] [Abstract][Full Text] [Related]
2. Clinical significance of IGF1R gene expression in patients with Stage II/III gastric cancer who receive curative surgery and adjuvant chemotherapy with S-1.
Numata K; Oshima T; Sakamaki K; Yoshihara K; Aoyama T; Hayashi T; Yamada T; Sato T; Cho H; Shiozawa M; Yoshikawa T; Rino Y; Kunisaki C; Akaike M; Imada T; Masuda M
J Cancer Res Clin Oncol; 2016 Feb; 142(2):415-22. PubMed ID: 26337161
[TBL] [Abstract][Full Text] [Related]
3. Tumor suppressor role of miR-133a in gastric cancer by repressing IGF1R.
Gong Y; Ren J; Liu K; Tang LM
World J Gastroenterol; 2015 Mar; 21(10):2949-58. PubMed ID: 25780292
[TBL] [Abstract][Full Text] [Related]
4. High-expression of DJ-1 and loss of PTEN associated with tumor metastasis and correlated with poor prognosis of gastric carcinoma.
Li Y; Cui J; Zhang CH; Yang DJ; Chen JH; Zan WH; Li B; Li Z; He YL
Int J Med Sci; 2013; 10(12):1689-97. PubMed ID: 24155657
[TBL] [Abstract][Full Text] [Related]
5. Impact of insulin-like growth factor-1 receptor and amphiregulin expression on survival in patients with stage II/III gastric cancer enrolled in the Adjuvant Chemotherapy Trial of S-1 for Gastric Cancer.
Ichikawa W; Terashima M; Ochiai A; Kitada K; Kurahashi I; Sakuramoto S; Katai H; Sano T; Imamura H; Sasako M
Gastric Cancer; 2017 Mar; 20(2):263-273. PubMed ID: 26884344
[TBL] [Abstract][Full Text] [Related]
6. Targeting the E3 ligase NEDD4 as a novel therapeutic strategy for IGF1 signal pathway-driven gastric cancer.
Wang K; Yu Y; Wang W; Jiang Y; Li Y; Jiang X; Qiao Y; Chen L; Zhao X; Liu J; Yang A; Li J; Zhang R
Oncogene; 2023 Mar; 42(14):1072-1087. PubMed ID: 36774408
[TBL] [Abstract][Full Text] [Related]
7. The influence of insulin-like Growth Factor-1-Receptor expression and endocrine treatment on clinical outcome of postmenopausal hormone receptor positive breast cancer patients: A Dutch TEAM substudy analysis.
Engels CC; de Glas NA; Sajet A; Bastiaannet E; Smit VT; Kuppen PJ; Seynaeve C; van de Velde CJ; Liefers GJ
Mol Oncol; 2016 Apr; 10(4):509-16. PubMed ID: 26706833
[TBL] [Abstract][Full Text] [Related]
8. Increased phosphorylation of 4E‑binding protein 1 predicts poor prognosis for patients with colorectal cancer.
Miao Y; Chen L; Shi C; Fan R; Chen P; Liu H; Xia A; Qian H
Mol Med Rep; 2017 May; 15(5):3099-3104. PubMed ID: 28339030
[TBL] [Abstract][Full Text] [Related]
9. Potential prognostic significance of p185(HER2) overexpression with loss of PTEN expression in gastric carcinomas.
Im SA; Lee KE; Nam E; Kim DY; Lee JH; Han HS; Seoh JY; Park HY; Cho MS; Han WS; Lee SN
Tumori; 2005; 91(6):513-21. PubMed ID: 16457151
[TBL] [Abstract][Full Text] [Related]
10. Is there a role for IGF1R and c-MET pathways in resistance to cetuximab in metastatic colorectal cancer?
Inno A; Di Salvatore M; Cenci T; Martini M; Orlandi A; Strippoli A; Ferrara AM; Bagalà C; Cassano A; Larocca LM; Barone C
Clin Colorectal Cancer; 2011 Dec; 10(4):325-32. PubMed ID: 21729677
[TBL] [Abstract][Full Text] [Related]
11. Expression and clinical evidence of miR-494 and PTEN in non-small cell lung cancer.
Wang J; Chen H; Liao Y; Chen N; Liu T; Zhang H; Zhang H
Tumour Biol; 2015 Sep; 36(9):6965-72. PubMed ID: 25861022
[TBL] [Abstract][Full Text] [Related]
12. Expression of miR-1294 is downregulated and predicts a poor prognosis in gastric cancer.
Shi YX; Ye BL; Hu BR; Ruan XJ
Eur Rev Med Pharmacol Sci; 2018 Sep; 22(17):5525-5530. PubMed ID: 30229824
[TBL] [Abstract][Full Text] [Related]
13. MicroRNA-377 predicts poor clinical outcome of gastric cancer and induces tumorigenesis by targeting multiple tumor-suppressor genes.
Wen X; Wu JQ; Peng W; Feng JF; Tang JH
Oncol Rep; 2015 Jul; 34(1):203-10. PubMed ID: 25998046
[TBL] [Abstract][Full Text] [Related]
14. Protein expression of PTEN, insulin-like growth factor I receptor (IGF-IR), and lethal prostate cancer: a prospective study.
Zu K; Martin NE; Fiorentino M; Flavin R; Lis RT; Sinnott JA; Finn S; Penney KL; Ma J; Fazli L; Gleave ME; Bismar TA; Stampfer MJ; Pollak MN; Loda M; Mucci LA; Giovannucci E
Cancer Epidemiol Biomarkers Prev; 2013 Nov; 22(11):1984-93. PubMed ID: 23983239
[TBL] [Abstract][Full Text] [Related]
15. Clinical Significance of Myeloid Zinc Finger 1 Expression in the Progression of Gastric Tumourigenesis.
Li GQ; He Q; Yang L; Wang SB; Yu DD; He YQ; Hu J; Pan YM; Wu Y
Cell Physiol Biochem; 2017; 44(3):1242-1250. PubMed ID: 29179204
[TBL] [Abstract][Full Text] [Related]
16. Negative expression of PTEN identifies high risk for lymphatic-related metastasis in human esophageal squamous cell carcinoma.
Sun Z; Ji N; Bi M; Zhang Z; Liu X; Wang Z
Oncol Rep; 2015 Jun; 33(6):3024-32. PubMed ID: 25963289
[TBL] [Abstract][Full Text] [Related]
17. Lack of any prognostic role of insulin-like growth factor-1 receptor in non-small cell lung cancer.
Dilli UD; Yildırim M; Suren D; Alikanoglu A; Kaya V; Goktas S; Yildiz M; Sezer C; Gunduz S
Asian Pac J Cancer Prev; 2014; 15(14):5753-7. PubMed ID: 25081697
[TBL] [Abstract][Full Text] [Related]
18. Downregulation of miR-519a Predicts Poor Prognosis and Contributes to Tumor Progression in Gastric Cancer.
Cai H; Lin H; Cao W; Sun J; Huang Y; Fang Y
Oncol Res Treat; 2020; 43(1-2):19-26. PubMed ID: 31743914
[TBL] [Abstract][Full Text] [Related]
19. miR-494 suppresses tumor growth of epithelial ovarian carcinoma by targeting IGF1R.
Li N; Zhao X; Wang L; Zhang S; Cui M; He J
Tumour Biol; 2016 Jun; 37(6):7767-76. PubMed ID: 26695144
[TBL] [Abstract][Full Text] [Related]
20. MicroRNA-7 functions as an anti-metastatic microRNA in gastric cancer by targeting insulin-like growth factor-1 receptor.
Zhao X; Dou W; He L; Liang S; Tie J; Liu C; Li T; Lu Y; Mo P; Shi Y; Wu K; Nie Y; Fan D
Oncogene; 2013 Mar; 32(11):1363-72. PubMed ID: 22614005
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
